Vindesine
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy category |
|
Routes of administration | Intravenous |
ATC code | L01CA03 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | 65-75% |
Metabolism | Hepatic (CYP3A4-mediated) |
Biological half-life | 24 hours |
Excretion | Biliary and renal |
Identifiers | |
| |
CAS Number | 59917-39-4 |
PubChem (CID) | 40839 |
DrugBank | DB00309 |
ChemSpider | 37302 |
UNII | RSA8KO39WH |
KEGG | D01769 |
ChEBI | CHEBI:36373 |
ChEMBL | CHEMBL219146 |
ECHA InfoCard | 100.053.330 |
Chemical and physical data | |
Formula | C43H55N5O7 |
Molar mass | 753.926 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Vindesine is an anti-mitotic vinca alkaloid used in chemotherapy. It is used to treat many different types of cancer, including leukaemia, lymphoma, melanoma, breast cancer, and lung cancer.
References
This article is issued from Wikipedia - version of the 10/17/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.